![Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques](https://www.frontiersin.org/files/Articles/1095059/fonc-12-1095059-HTML/image_m/fonc-12-1095059-g001.jpg)
Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques
![Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/09/k2.png?w=640)
Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK
![Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-023-10700-0/MediaObjects/12885_2023_10700_Fig1_HTML.png)
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text
![Cancers | Free Full-Text | Artificial Intelligence Techniques for Prostate Cancer Detection through Dual-Channel Tissue Feature Engineering Cancers | Free Full-Text | Artificial Intelligence Techniques for Prostate Cancer Detection through Dual-Channel Tissue Feature Engineering](https://pub.mdpi-res.com/cancers/cancers-13-01524/article_deploy/html/images/cancers-13-01524-g001.png?1627961275)
Cancers | Free Full-Text | Artificial Intelligence Techniques for Prostate Cancer Detection through Dual-Channel Tissue Feature Engineering
![Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/2/e040531/F1.large.jpg)
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open
![The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0349-1/MediaObjects/41585_2020_349_Fig1_HTML.png)
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/CPG-chart.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep33818/MediaObjects/41598_2016_Article_BFsrep33818_Fig1_HTML.jpg)
Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports
![Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/ad4f7df5-b2d3-4fe9-87d0-d22547326edf/gr1.gif)
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/CPG-mortality-charts.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/8ab1a23f-71c9-42e5-9542-5365a452035a/gr1.jpg)
Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus
![Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-021-03909-z/MediaObjects/41419_2021_3909_Fig1_HTML.png)
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease
![Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey - European Urology Focus Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/97715ffe-9cb5-4036-af5b-bbfc5f8efc06/gr1.jpg)
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey - European Urology Focus
![Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study](https://www.frontiersin.org/files/Articles/770169/fsurg-08-770169-HTML/image_m/fsurg-08-770169-g001.jpg)
Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://pub.mdpi-res.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g002.png?1571415812)